SINGAPORE (July 9): Since its IPO in May last year, Hyphens Pharma International, the specialty pharmaceutical and consumer healthcare group, has gradually been building up its presence, both locally and in the region.
In 2018, Hyphens launched five products but more are expected this year with two dermatological products – Ceradan Advanced and TDF Fairence T-Complex – pending commercialisation.
According to Hyphens, Ceradan Advanced could be a potential bestseller given the product has a pH-balancing mechanism and contains ceramide which forms a barrier on the skin and helps it retain moisture.
For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
